Literature DB >> 17388943

Extensive cortical remyelination in patients with chronic multiple sclerosis.

Monika Albert1, Jack Antel, Wolfgang Brück, Christine Stadelmann.   

Abstract

Recent studies revealed prominent cortical demyelination in patients with chronic multiple sclerosis (MS). Demyelination in white matter lesions is frequently accompanied by remyelination. This repair process, however, often remains incomplete and restricted to the lesion border. In the present study, we examined the frequency and extent of remyelination in cortical and white matter lesions in autopsy brain tissue of 33 patients with chronic MS. The majority of patients (29 of 33) harbored cortical demyelination. Remyelination of cortical lesions was identified light microscopically by the presence of thin and irregularly arranged myelin sheaths, and confirmed by electron microscopy. Extensive remyelination was found in 18%, remyelination restricted to the lesion border in 54%, and no remyelination in 28% of cortical lesions. A direct comparison of the extent of remyelination in white matter and cortical lesions of the same patients revealed that remyelination of cortical lesions was consistently more extensive. In addition, g-ratios of fibers in areas of "normal appearing cortex" yielded values consistent with remyelination. Our data confirm the high prevalence of cortical demyelination in chronic MS and imply that the propensity to remyelinate is high in cortical MS lesions.

Entities:  

Mesh:

Year:  2007        PMID: 17388943     DOI: 10.1111/j.1750-3639.2006.00043.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  95 in total

1.  Analysis of White Matter Damage in Patients with Multiple Sclerosis via a Novel In Vivo MR Method for Measuring Myelin, Axons, and G-Ratio.

Authors:  A Hagiwara; M Hori; K Yokoyama; M Nakazawa; R Ueda; M Horita; C Andica; O Abe; S Aoki
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-03       Impact factor: 3.825

2.  Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report.

Authors:  F Rinaldi; M Calabrese; D Seppi; M Puthenparampil; P Perini; P Gallo
Journal:  Neurol Sci       Date:  2011-01       Impact factor: 3.307

Review 3.  Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.

Authors:  Ranjan Dutta
Journal:  Mult Scler       Date:  2013-09       Impact factor: 6.312

4.  Effects of formalin fixation on magnetic resonance indices in multiple sclerosis cortical gray matter.

Authors:  Klaus Schmierer; Janet R Thavarajah; Shu F An; Sebastian Brandner; David H Miller; Daniel J Tozer
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

Review 5.  Neuroprotection and neuroregeneration in multiple sclerosis.

Authors:  Martin Stangel
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

6.  Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain.

Authors:  Francesca Viganò; Wiebke Möbius; Magdalena Götz; Leda Dimou
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

Review 7.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

Review 8.  Myelin repair strategies: a cellular view.

Authors:  Vittorio Gallo; Regina C Armstrong
Journal:  Curr Opin Neurol       Date:  2008-06       Impact factor: 5.710

Review 9.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

Review 10.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.